Evan Feinberg, Ph.D.
Founder and CEO, Genesis Molecular AI
Dr. Evan Feinberg is founder and CEO of Genesis Molecular AI, which he founded in 2019 to apply AI and simulation research from Vijay Pande’s lab at Stanford University. Genesis has raised more than $340 million, signed collaborations with Gilead and Incyte and been recognized on the Forbes AI 50 list for several consecutive years. Feinberg has also been named to the Forbes 30 Under 30 list.